• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Tacrocel
    / Perrigo


    Active Ingredient
    Tacrolimus (as monohydrate) 0.5, 1, 5 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Capsules

    50 X 0.5 mg

    partial basket chart 38112 20745

    Capsules

    100 X 1 mg

    partial basket chart 38113 20746

    Capsules

    50 X 5 mg

    partial basket chart 38114 20747

    Related information


    Dosage

    One capsule twuca a day, on an empty stomach, or at least one hour before or 2-3 hours after a meal.
    Swallow the capsules whole with a glass of water immediately following its removal from the blister.
    Not to be taken with grapefruits or grapefruit juice.
    See prescribing information for full details.


    Indications

    Prophylaxis of transplant rejection in liver, kidney or heart allograft recipients. Treatment of allograft rejection resistant to treatment with other immunosuppressive medical products.


    Contra-Indications

    Hypersensitivity to the active ingredient or to any of the excipients. Hypersensitivity to antibiotics of the macrolide group. Lactation. Coadministration with cyclosporine.


    Special Precautions

    Substitution with another tacrolimus product is not allowed, unless the physician in the transplant unit is aware of the substitution and has approved it. See prescribing information for full details.


    Important notes

    Do not replace with another tacrolimus preparation, unless the doctor from the transplant clinic approves it.


    Manufacturer
    Lek Pharmaceuticals
    CLOSE